MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS

被引：0
|
作者：
Naidoo, Jarushka [1 ]
Noonan, Sinead [2 ]
Teo, Min Yuen [3 ]
Rho, Young Soo [1 ]
Clince, Janet [1 ]
Gately, Kathy [4 ]
O'Grady, Tony [5 ]
Kaye, Elaine [5 ]
Calvert, Paula [6 ]
Morris, Patrick G. [7 ]
O'Brien, Cathal [4 ]
O'Byrne, Kenneth [8 ]
Breathnach, Oscar S. [1 ]
机构：
[1] Beaumont Hosp, Dublin, Ireland
[2] St James Hosp, Dublin, Ireland
[3] Inc Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin 24, Ireland
[4] Univ Dublin Trinity Coll, Dublin 2, Ireland
[5] Beaumont Hosp, Dublin, Ireland
[6] Waterford Reg Hosp, Waterford, Ireland
[7] Hermitage Clin, Dublin, Ireland
[8] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Treatment; non-small cell lung cancer; Cinical Trials; Inequality;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-042
引用
收藏
页码：S1208 / S1208
页数：1
相关论文
共 50 条
  • [31] β-catenin in non-small cell lung cancer (NSCLC)
    Swinson, DEB
    Lolljee, J
    Edwards, JG
    Jones, JL
    Cox, G
    Richardson, D
    O'Byrne, KJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S59 - S60
  • [32] Micrometastases in non-small cell lung cancer (NSCLC)
    Passlick, B
    LUNG CANCER, 2001, 34 : S25 - S29
  • [33] Immunotherapy for non-small cell lung cancer (NSCLC)
    Frost, Nikolaj
    Reck, Martin
    INNERE MEDIZIN, 2022, 63 (07): : 709 - 716
  • [34] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [35] Molecular characteristics of HRAS mutated non-small cell lung cancer (NSCLC)
    Trabolsi, Asaad
    Rodriguez, Estelamari
    Kareff, Samuel Alexander
    Korn, Michael
    Xiu, Joanne
    Liu, Stephen
    Walker, Philip
    Ma, Patrick
    Mamdani, Hirva
    Nieva, Jorge
    Borghaei, Hossein
    Nabhan, Chadi
    Nagasaka, Misako
    Puri, Sonam
    Lopes, Gilberto
    CANCER RESEARCH, 2022, 82 (12)
  • [36] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    Investigational New Drugs, 2000, 18 : 29 - 42
  • [37] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Molecular Based Patient Selection in Global Clinical Trials for Non-Small Cell Lung Cancer
    Okamoto, I.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S74 - S74
  • [40] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
12345